Detalhe da pesquisa
1.
Efficacy and safety of rucaparib in previously treated, locally advanced or metastatic urothelial carcinoma from a phase 2, open-label trial (ATLAS).
BMC Cancer
; 21(1): 593, 2021 May 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34030643
2.
Utilization of redox modulating small molecules that selectively act as pro-oxidants in cancer cells to open a therapeutic window for improving cancer therapy.
Redox Biol
; 42: 101864, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33485837